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Background: Levofloxacin hemihydrate (LEV) and ambroxol HCl (AMB) are available for the treatment of upper and
lower respiratory tract infections. A survey of the literature reveals that two reversed phase HPLC methods were e
reported for the simultaneous determination of LEV and AMB in pharmaceutical preparations. However the
reported methods suffers from the low sensitivity, no application of the method in the combined tablets and no
application to biological fluids. Also the toxic effects of the used solvents which are harmful to human beings. For
this reason, our target was to develop a simple sensitive, less hazardous micellar HPLC method for the simultaneous
determination of LEV and AMB in their combined dosage forms and plasma.
Results: The method showed good linearity over the ranges of 1–44 μg/mL and 1–20 μg/mL with limits of
detection 0.26 and 0.07 μg/mL and limits of quantification 0.80 and 0.20 μg/mL for LEV and AMB, respectively. The
method was further extended to the determination of LEV in spiked human plasma with mean percentage
recoveries of 100.10% ± 1.14 as well as determination of LEV in real human plasma without prior extraction.
Statistical evaluation of the data was performed according to ICH Guidelines.
Conclusion: The suggested method was successfully applied for the simultaneous analysis of the studied drugs
in their co-formulated tablets and human plasma. The mean percentage recoveries in combined tablets were
100.20 ± 1.64 and 100.72 ± 1.11 for LEV and AMB, respectively and 100.10 ± 1.14 for LEV in spiked human plasma.
Statistical comparison of the results with those of the comparison method revealed good agreement and proved
that there were no significant difference in the accuracy and precision between the two methods respectively.
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Human plasmaBackground
MLC is a mode of reversed phase liquid chromatography
(RPLC), in which the mobile phases are aqueous solutions
of a surfactant at a concentration above the critical micel-
lar concentration (cmc). Anionic sodium dodecyl sulphate
(SDS) is the most widely used surfactant in MLC, but neu-
tral Brij-35 or cationic N-cetyltrimethylammonium chlor-
ide are also used. In these media, the great variety of
interactions between the solutes, micelles and stationary* Correspondence: samar_3alim@yahoo.com
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Mansoura, Mansoura 35516, Egypt
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reproduction in any medium, provided the orphase makes MLC a highly versatile technique, which is
appropriate for a wide range of solutes (hydrophilic and
hydrophobic compounds) that can be separated in the
same run.
Most procedures for the determination of compounds
by MLC make use of micellar mobile phases containing
an organic modifier (hybrid micellar mobile phases),
which is usually a short-chain alcohol (methanol, pro-
panol, butanol or pentanol) or acetonitrile. These modi-
fiers increase the elution strength and often improve the
shape of the chromatographic peaks. The modifiers solv-
ate the bonded stationary phase and reduce the amountLtd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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concentration and the hydrophobicity of the alcohol in-
creases. Selection of the pH of the mobile phase is also
often important for the resolution of complex mixture, be-
cause of the side acid–base reactions of many solutes [1].
Levofloxacin hemihydrate (LEV) Figure 1a, (−)-S-9-
fluoro-2,3-dihydro-3-methyl-10-(4-methyl)-1-piperazinyl)-
7-oxo-7H-pyrido[1,23-de]-1,4-benzooxazine-6-carboxylic
acid is second generation fluoroquinolones [2]. It is the S-
(−)-isomer of ofloxacin [2] and acts as antibacterial by
inhibiting DNA gyrase and topoisomerase IV enzyme [3].
It is the subject of a monograph in the United States
pharmacopoeia USP [3].
Ambroxol hydrochloride (AMB) Figure 1b, trans-4-(2-
amino-3, 5-dibromobenzylamino)cyclohexanol hydrochlo-
ride [2] is used as mucolytic expectorant [4]. The drug is
the subject of a monograph in the British pharmacopoeia
BP [5].
The literature revealed many methods for the deter-
mination of LEV; including a review on the spectro-
photometric methods for its determination up to 2008
[6], other specrophotometric methods [7-9], spectro-
fluorometric methods [10,11], HPLC with UV detection
[12,13], fluorometric detection [14], tandem mass spec-
trometric detection [15]. Capillary electrophoresis with
electrochemiluminescence detection [16], electroche-
mical methods [17], chemiluminescence [18] and flow
injection analysis with UV, potentiometric and conducto-
metric detection [19] were also reported.
Regarding AMB: several methods were also described
for its determination either per se or in pharmaceutical
preparations;including potentiometric titration [5] using
alcohol as a solvent, adding 0.01 M hydrochloric acid
and titration using 0.1 M sodium hydroxide. AMB was
determined using spectophotometric methods [20,21],
stability indicating HPTLC [22]. HPLC with UV de-
tection [23-25], mass spectrometric detection [26], po-
tentiometric detection [27], amperometric detection
[28], GC [29], flow injection analysis [30,31], micellar(a) Levofloxain hemihydrates                          
Figure 1 The structural formulae of the studied drugs. (a) Levofloxainelectrokinetic capillary chromatographic method [32]
and electrochemical methods [33,34].
Both drug were simultaneously determined by HPLC
[35], TLC [36] and UV spectrophotometry [37]. A fixed
dose of LEV and AMB is available for the treatment of
upper and lower respiratory tract infections.
To the best of our knowledge no method has been
reported concerning the analysis of such mixture using a
micellar liquid chromatographic method, a mobile phase
containing surface active agent (SAA) was useful for the
analysis of LEV in spiked and real human plasma, since
SAA dissolves the amino acids present in human
plasma, therefore no need for prior extraction step
which is time consuming and decrease the hazardous ef-
fect of using organic solvent.
In the present work, a micellar HPLC method with
UV detection was utilized for the simultaneous analysis
of LEV and AMB with good resolution within retention
times less than 6 min. This method could be applied for
the quantitative determination of the studied drugs in
their and prepared co-formulated tablets, as well as de-




 Chromatographic separation was carried out using
a Merck Hitachi Chromatograph model L-7100
equipped with a Rheodyne injector valve with a
20 μL loop, and a Merck Hitachi L-7400 UV
detector operated at 220 nm. The chromatograms
were recorded on a Merck Hitachi D-7500
integrator. Mobile phase was filtered using
Millipore filter Sibata and degassed using Merck
solvent L-7612 degasser.
 A Consort P-901 pH-meter was used for pH
measurements.
 Ultrasonic bath, model SS 101 H 230, USA.                   (b) Ambroxol HCl
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Figure 2 Typical chromatogram of synthetic mixture of 25 μg/
mL LEV and 6 μg/mL AMB using 8 μg/mL FUR (I.S) in 0.15 M
SDS, 0.3% triethylamine, 8% n-propanol all prepared in 0.02 M
orthophosphoric acid at pH 4.0.
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All the chemicals used were of Analytical Reagent Grade,
and the solvents were of HPLC grade.
 LEV was kindly provided by EUROPEAN
EGYPTIAN PHARMACEUTICALS company, batch
# KYLFAM20090605B.
 AMB was kindly provided by GlaxoSmithkline, S. A.
E. Elsalam city, Egypt, batch # VBNOB2011.
 Furosemide (FUR), used as the internal standard
(IS), was kindly donated by Alexandria CO. for
Pharmaceuticals, Alexandria, Egypt.
 Leeflox® tablets, manufactured by Pharonia
Pharmaceuticals New Borg EL-Arab city, Egypt,
batch # 1131002, labeled to contain 250 mg LEV.
 Ambroxol® tablets, Manufactured by
GlaxoSmithkline, S. A. E. Elsalam city, Egypt, batch
# 1020144, labeled to contain 30 mg AMB.
 Sodium dodecyl sulphate (SDS) 90%, triethylamine
(TEA) and orthophosphoric acid 85% were obtained
from Riedel-deHäen (Sleeze, Germany).
 Methanol, n-propanol and acetonitrile (HPLC grade)
were obtained from Sigma- Aldrich (Germany).
 Human plasma was kindly provided by Mansoura
University Hospitals, Mansoura, Egypt and kept
frozen (−5°C) until used after gentle thawing.
Chromatographic conditions
Column: Spherisorb-ODS 2 C18 column (150 mm × 4.6
mm i.d., 5 μm particle size) Shimadzu, Kyoto, Japan. The
column hold up value was the first deviation of the base
line obtained.
Mobile phase: a solution consists of 0.15 M SDS, 8%
n-propanol, 0.3% TEA, prepared in 0.02 M orthophos-
phoric acid. The pH of the mobile phase was adjusted to
pH 4.0 using orthophosphoric acid and the flow rate was
1 mL/min.
The column was operated at room temperature and
the wavelength was monitored at 220 nm. FUR was se-
lected as the internal standard since it gave good reso-
lution with both LEV and AMB.
Standard solutions
Stock solutions of 200 μg/mL of LEV, 200 μg/mL of
AMB and 200 μg/mL of FUR (IS) were prepared by dis-
solving 20.0 mg of LEV, AMB and of FUR separately in
100 mL of methanol with the aid of an ultrasonic bath.
Working standard solutions were prepared by appro-
priate dilution of the stock solutions with methanol.
Standard laboratory prepared mixture solutions were
prepared by mixing appropriate volumes of LEV and
AMB stock solutions in 50 mL volumetric flasks and
diluting to the volume with methanol keeping the me-
dicinally recommended ratios of 25: 6 for LEV andAMB, respectively. All solutions were stored in the re-
frigerator and found to be stable for at least 10 days
without alteration.
Procedures
Construction of calibration graphs
Accurately measured aliquot volumes of the suitable drug
working standard solutions were transferred into a series
of 10 mL volumetric flasks so that the final concentration
was in the range of 1–44 μg/mL for LEV and 1–20 μg/mL
for AMB. To each flask, 8 μg/mL (final concentration) of
FUR standard solution was added as internal standard.
Then, the solutions were completed to the volume with
the mobile phase. Aliquots of 20 μL were injected (tripli-
cate) and eluted with the mobile phase under the
optimum chromatographic conditions. The average peak
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drugs in μg/mL was plotted. Alternatively, the correspond-
ing regression equations were derived.
Analysis of LEV/AMB Laboratory prepared mixtures
Aliquots of LEV and AMB standard laboratory prepared
mixture solutions were transferred into a series of 10-mL
volumetric flasks. To each flask, 8 μg/mL (final concentra-
tion) of FUR standard solution was added as internal
standard. Then, the solutions were completed to the vol-
ume with the mobile phase. The solutions were diluted to
the mark with the mobile phase and mixed well. The
above procedure described under “Construction of the
Calibration Graphs” was then performed. The percentage
recoveries were calculated by referring to the calibration
graphs, or using the corresponding regression equations.
Analysis of LEV and AMB in their single tablets
An accurately weighed quantity of the mixed contents of
10 powdered Leeflox® or Ambroxol® tablets equivalent toTable 1 Effect of experimental parameters on the number of
Parameter Numbe
LEV
























1.8 137020.0 mg of LEV and AMB, respectively were transferred
separately into a 100 mL volumetric flasks and 80 mL of
methanol were added. The contents of the flask were soni-
cated for 30 min, completed to the volume with the same
solvent, mixed well and filtered. Aliquots containing suit-
able concentrations of the studied drugs were analyzed as
described under “construction of calibration graphs”. The
nominal content was calculated either from a previously
plotted calibration graph or using the corresponding re-
gression equation.
Analysis of the studied drugs in their co-formulated tablets
Laboratory prepared tablets containing 250 mg of LEV
and 60 mg of AMB were mixed with tablet excipients;
lactose (15) mg, starch (15) mg, talc (20) mg and magne-
sium stearate (10) mg per each tablet. An accurately
weighed quantity of the mixed contents of 10 prepared
tablets equivalent to 25.0 mg LEV and 6.0 mg AMB
(according to their pharmaceutical ratio) was transferred
into 100 mL volumetric flasks and 80 mL of methanoltheoretical plates, resolution and selectivity factor





























Table 2 Analytical performance data for the
determination of the LEV and AMB by the proposed
method
Parameter LEV AMB
Linearity range (μg/mL) 1- 44 1-20
Intercept (a) −0.086 −0.037
Slope (b) 0.0682 0.0748
Correlation coefficient (r) 0.9999 0.9999
SD of residuals (Sy/x) 8.5 × 10
-3 1.9 × 10-3
SD of intercept (Sa) 5.5 × 10
-3 1.5 × 10-3
SD of slope (Sb) 2.00 × 10
-4 1.00 × 10-4
Percentage relative standard deviation, % RSD 0.762 1.425
Percentage relative error, % Error 0.288 0.640
Limit of detection, LOD (μg/mL) 0.26 0.07
Limit of quantitation, LOQ (μg/mL) 0.80 0.20
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for 30 min, completed to the volume with the same
solvent, mixed well and filtered. Aliquots containing
suitable concentrations of the studied drugs over the
working concentration range were analyzed as de-
scribed under “construction of calibration graphs”. The
nominal content was calculated either from a previously
plotted calibration graphs or using the corresponding
regression equations.
Analysis of LEV in spiked human plasma
Aliquots of LEV working standard solution was trans-
ferred into a series of 10 mL volumetric flasks, so that
its final concentration is in the range of 1–3 μg/mL. The
contents of the flasks were diluted to about 8 mL with
the mobile phase, to prevent plasma protein precipita-
tion with methanol (solvent of LEV), 1 mL of human
plasma was added to each flask, and the volumes were
completed to the mark with the mobile phase and mixed
well. Aliquots of 20 μL were injected (triplicate) and
eluted with the mobile phase under the reported chro-
matographic conditions. A blank experiment was carried
out simultaneously. The peak area was plotted versus
the concentration of the drug in μg/mL.
Procedure for patient samples
A healthy volunteer (female, 30 years old) had been ad-
ministered Leeflox 750 mg® tablet after 10 hours of
fasting. A blood sample was taken from the volunteer
before administration of the tablets as a blank. Then,
blood samples were collected at several time intervals
after oral administration. The samples were drawn into
test tubes containing EDTA as anticoagulant and
centrifuged at 4000 rpm for 30 min. The supernatant
plasma was transferred into test tubes. 1 mL aliquots
of the supernatant plasma were transferred into a
series of 10 mL volumetric flasks. The procedure de-
scribed under the analysis of spiked human plasma was
then followed.
Results and discussion
The proposed method permitted good separation of
LEV and AMB with resolution factor (Rs) = 3.81 and se-
lectivity factor (α) = 2.45 in a reasonable time less than 6
min. Figure 2 Illustrates a typical chromatogram for a la-
boratory prepared mixture of the two studied drugs
under the described chromatographic conditions. The
retention times for LEV and AMB were 3.4 and 5.2 min.,
respectively. The proposed method offers high sensitivity
since 1 μg/mL of LEV and 1 μg/mL of AMB could be
determined accurately. It also permitted the accurate
analysis of the studied drugs in their co-formulated tab-
lets and the analysis of LEV in spiked as well as in real
human plasma.Optimization of the chromatographic performance and
system suitability
Well-defined symmetrical peaks were obtained after
thorough experimental trials that can be summarized
as follows:
Choice of column
Two different columns were used for performance inves-
tigations, including: Spherisorb-ODS 2 C18 column (150
mm × 4.6 mm i.d., 5 μm particle size) and Symmetry®
C18 column (250 mm × 4.6 mm i.d., 5 μm particle size),
The experimental studies revealed that the first column
was the most suitable since it produced symmetrical
peaks with high resolution. The second column was not
suitable for the analysis since it resulted in delay in re-
tention times, 10.3 min for LEV and 48 min for AMB.
Choice of appropriate wavelength
Five wavelengths (220, 230, 248, 300 and 310 nm) were
tried to detect the most suitable one for analysis and
separation of both drugs. The UV detector response of
both drugs was studied and the most suitable wave-
length was found to be 220 nm showing the highest sen-
sitivity with a reasonable response and good separation
for both drugs.
Mobile phase composition
Several modifications in the mobile phase composition
were performed in order to study the possibilities of
improving the performance of the chromatographic
system. These modifications included the change of
the type and % concentration of the organic modifier,
the concentration of SDS and the pH. The results
obtained are abridged in Table 1.
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Different organic modifiers were tried during the experi-
mental study to choose the most suitable one for chro-
matographic separation of the two drugs. The studied
organic modifiers included methanol, acetonitrile, n-
propanol, 2-propanol and absolute ethanol. It was found
that; using methanol and absolute ethanol showed over-
lapping of the studied drugs, while 2-propanol and
acetonitrile showed slight overlapping, a little delay in
retention times and decrease in number of theoretical
plates, especially for AMB. In addition, methanol, etha-
nol, acetonitrile and 2-propanol showed lower sensiti-
vity. So, n-propanol was the organic modifier of choice
giving good resolved and highly sensitive peaks within a
reasonable time (less than 6 min.).
Concentration of organic modifier (%)
The effect of changing the % concentration of n-
propanol on the selectivity and retention times of the
test solutes was investigated using mobile phases
containing concentrations of 6–14% of n-propanol. It
was found that the retention times of both LEV and
AMB decreased upon increasing the % concentration of
n-propanol. The study revealed that the optimum chro-
matographic performance was achieved upon using 8%
n-propanol regarding the resolution of the two drugsTable 3 Assay results for the determination of LEV and AMB
Compound Proposed method



















N.B. Each result is the average of three separate determinations.
The figures between parentheses are the tabulated t and F values at P = 0.05 [38].and number of theoretical plates. Concentrations less
than 6% resulted in a broad and less sensitive peaks and
it was time consuming, whereas concentrations higher
than 14% decreased number of theoretical plates for
both drugs.
Concentration of SDS, M
The effect of changing the concentration of SDS on the
selectivity and retention times of the test solutes was
investigated using mobile phases containing a concen-
tration of 0.05–0.2 M SDS. It was found that the reten-
tion times of both LEV and AMB decreased upon
increasing the % concentration of SDS. The study re-
vealed that the optimum chromatographic performance
was achieved upon using 0.15 M SDS regarding the
resolution of the two drugs and number of theoretical
plates. Concentrations less than 0.05 M SDS resulted in
great increase in the retention time, whereas concen-
trations higher than 0.2 M SDS decreased number of
theoretical plates.
pH
The effect of changing the pH of the mobile phase on
the selectivity and retention times of the test solutes
was investigated using mobile phases of pH ranging
from 3–7. It was found that the retention times of bothin pure form
Comparison method (35)
















100.45 ± 1.43 100.00 ± 0.41
0.51 (2.45)
12.31 (19.25)
Table 4 Precision data for the determination of LEV and AMB by the proposed method
Parameters LEV concentration (μg/mL) AMB concentration (μg/mL)
15.0 20.0 32.5 3.6 4.8 6.0
Intraday
% Found 98.15 99.48 102.89 97.67 98.97 102.23
97.00 98.82 100.93 102.99 102.06 101.01
99.94 97.06 99.29 98.33 99.23 98.00
Xð Þ 98.36 98.45 101.04 98.45 100.09 101.04
± SD 1.48 1.25 1.80 1.25 1.71 1.80
% RSD 1.51 1.27 1.78 1.27 1.71 1.78
% Error 0.87 0.73 1.03 0.73 0.99 1.03
Interday
% Found 98.55 99.95 101.09 100.19 100.31 101.69
98.92 99.03 99.20 99.22 102.03 100.51
100.18 100.80 100.89 98.82 99.90 99.88
Xð Þ 99.22 99.93 100.39 99.41 100.75 100.69
± SD 0.86 0.89 1.04 0.70 1.13 0.92
% RSD 0.86 0.89 1.04 0.71 1.12 0.91
% Error 0.50 0.51 0.60 0.41 0.65 0.53
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pH. However increasing pH greater than 4 resulted in
decrease of number of theoretical plates of LEV. Table 1
illustrates that pH 4.0 was the most appropriate one
yielding well resolved peaks and the highest number of
theoretical plates.Flow rate
The effect of flow rate on the formation and separation
of peaks of the studied compounds was investigated over
the range of 0.6-1.4 mL/min. A flow rate of 1 mL/min.
was optimal for highest plate count and good separation
in a reasonable time, Table 1.Table 5 Assay results for the determination of LEV and AMB
case in tablets
LEV/AMB ratio
Amount taken Amount fou
(μg/mL) (μg/mL)
LEV AMB LEV








FThe nature of internal standard
Different internal standards such as triclabendazole,
spironolactone, xipamide, trimethoprim and furosemide
were investigated. Furosemide was the internal standard
of choice as it produced highest resolution factor and
good separation from the peaks of the two drugs.Method validation
Linearity and range
Under the above described experimental conditions, a lin-
ear relationship was established by plotting the peak area
ratio [drug/I.S.] against the drug concentration in μg/mL.
The concentration range was found to be 1–44 μg/mL forin their laboratory prepared mixture in 25:6 (w/w) as the
nd
% Found Comparisonmethod (35)
AMB LEV AMB LEV AMB
5.0100 98.00 100.20 99.35 100.26
6.1680 99.00 102.80 100.96 99.53
10.1450 98.33 101.45 99.49 100.21
98.44 101.48 99.93 100.00
0.61 1.30 0.89 0.41
0.52 1.28 0.89 0.41
0.0.30 0.74 0.52 0.24
2.528
3.064
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Retention time, min
a b
Figure 3 Chromatogram of (a) 25 μg/mL LEV in its single (Leeflox®) and (b) 6 μg/mL AMB in its single (Ambroxol®) tablet using
8 μg/mL FUR (I.S) in 0.15 M SDS, 0.3% triethylamine, 8% n-propanol all prepared in 0.02 M orthophosphoric acid at pH 4.0.
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of the data gave the following equations:
PA ¼ ‐ 0:0185þ 0:0682C r ¼ 0:9999ð Þ for LEV
PA ¼ ‐ 0:0370þ 0:0748C r ¼ 0:9999ð Þ for AMB
Where: P is the peak area ratio, C is the concentration
of the drug in μg/mL and r is the correlation coefficient.
The high values of the correlation coefficients with
small intercept indicate the good linearity of the calibra-
tion graph.
Statistical analysis [38] of the data gave high value of
the correlation coefficient (r) of the regression equa-
tions. Small values of the standard deviation of resid-
uals (Sy/x), of intercept (Sa), and of slope (Sb) indicate
low scattering of the points around the calibration
curves. Also, small values of the percentage relative
standard deviation (RSD %) and the percentage relative
errors (% Er) indicate high accuracy and high precision
of the proposed method, Table 2.
Limit of Quantitation (LOQ) and Limit of Detection (LOD)
The limit of quantitation (LOQ) was determined by
establishing the lowest concentration that can be mea-
sured according to ICH Q2R1 recommendations [38]
below which the calibration graph is non linear. The limitof detection (LOD) was determined by establishing the
minimum level at which the analyte can be reliably
detected [39].
LOQ ¼ 10 Sa=b LOD ¼ 3:3 Sa=b
Where Sa = standard deviation of the intercept of the
calibration curve and b = slope of the calibration curve.
LOQ values were found to be 0.80, 0.20 μg/mL while
LOD values were found to be 0.26, 0.07 μg/mL for LEV
and AMB, respectively as shown in Table 2.
Accuracy and precision
To prove the accuracy of the proposed method, the
results of assay of the studied drugs were compared
with those obtained using the comparison method
[35]. Statistical analysis of the results obtained using
Student's t-test and variance ratio F-test [38] revealed
no significant difference between the performance of
the two methods regarding the accuracy and precision,
respectively Table 3.
The comparison method depends on using reversed
phase HPLC for simultaneous determination of LEV and
AMB using phosphate buffer – acetonitrile – methanol
(650:250:100)v/v and pH adjusted to 5.2 with dilute ortho-
phosphoric acid as the mobile phase and C18 column with
UV detection at 220 nm [35]. The proposed procedure
Table 6 Assay results for the determination of LEV and AMB in their single tablet by the proposed and
comparison methods
Preparation
Proposed method Comparison method (35)
Amount taken Amount found




4.0 3.9180 97.97 100.10
20.0 19.9980 99.99 99.02
25.0 25.0100 100.04 98.16
X ± SD 99.31 ± 1.22 99.09 ± 0.97
% RSD 1.23 0.98





4.0 4.0800 102.00 100.68
8.0 8.2070 102.59 103.35
16.0 16.0360 100.23 101.60
x ± SD *101.60 ± 1.23 *101.88 ± 1.36
% RSD 1.21 1.33
% Error 0.70 0.77
t-test 0.26 (2.78)
F-test 1.22 (19.00)
N.B. Each result is the average of three separate determinations.
* Figures between parentheses are the tabulated t and F values, respectively at p = 0.05 [38].
Average LEV concentration found in Leeflox tablet 248.275 mg and average AMB found in Ambroxol tablet 30.48 mg.
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that the former is extended to the analysis of both drugs
in human plasma. Moreover, using micellar mobile phase
has the advantage of being low toxic due to the small
amount of solvent employed. In addition, no need for pre-
treatment step for the analysis of human plasma.
Intra-day precision was assessed by analyzing three con-
centrations and three replicates of each concentration in
















N.B. Each result is the average of three separate determinations.
The values of tabulated t and F tests are 2.78 and 19.00 respectively at p = 0.05 [38
Average LEV concentration found in tablet 250.50 mg and average AMB found 60.1analyzing three concentrations and three replicates of each
concentration over three successive days. The relative
standard deviations were found to be very small indicating
reasonable repeatability and intermediate precision of the
proposed method Table 4.
Robustness of the method
The robustness of the proposed method was indicated
by the constancy of the peak area ratio with deliberatein their prepared tablets
t found
% Found Comparisonmethod (35)/mL)
AMB LEV AMB LEV AMB
6.0020 100.60 100.04 100.10 100.68
1.2010 98.40 100.12 99.02 103.35
4.8250 98.89 102.00 98.16 101.60
100.20* 100.72 99.09 101.88
±1.64 ±1.11 ±0.97 ±1.36
1.63 1.10 0.98 1.33




4 mg per tablet.
Table 8 Assay results for the determination of LEV in
spiked human plasma using the proposed method
Parameter






x ± SD 100.10 ± 1.14
% RSD 1.13
% Error 0.66










































Figure 4 Typical chromatogram of co-formulated prepared
tablet of 25 μg/mL LEV and 6 μg/mL AMB using 8 μg/mL FUR
(I.S) in 0.15 M SDS, 0.3% triethylamine, 8% n-propanol all
prepared in 0.02 M orthophosphoric acid at pH 4.0.
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included n-propanol concentration, SDS concentration
and pH of the mobile phase. These minor changes didn’t
greatly affect the peak area ratios of both drugs.
Selectivity
The selectivity of the method was investigated by ob-
serving any interference encountered from common
tablet excipients. It was shown that these compounds
did not interfere with the results of the proposed
method. Additionally, there was not any interference
encountered from human plasma matrix although no
prior extraction procedure was performed.
Applications
Analysis of LEV/AMB laboratory prepared mixtures
The proposed method was applied to the simultaneous
determination of LEV and AMB in laboratory prepared
mixtures in the recommended pharmaceutical ratios
of 25:6 Figure 2. The concentrations of both drugs in
the laboratory prepared mixtures were calculated ac-
cording to the linear regression equations of the cali-
bration graphs. The results obtained by the proposed
method were in good agreement with those obtained
using the comparison method [35]. The high per-
centage recoveries and the small values of the relative
standard deviations and percentage relative errors indi-
cate the high accuracy and precision of the proposed
method, respectively. The results obtained are shown
in Table 5. It was concluded that good recoveries were




The proposed method was successfully applied to the
assay of both LEV and AMB in their single tablets as il-
lustrated in Figures 3a and b. The results of the pro-
posed method were favorably compared with those
obtained using the comparison method [35]. Theresults are abridged in Table 6. Statistical analysis of
the results obtained using Student’s t-test and variance ra-
tio F-test [38] revealed no significant difference between
the performance of the two methods regarding the accur-
acy and precision, respectively Table 6.
The proposed method was further applied to the
determination of the studied drugs in their co-
formulated laboratory prepared tablets. The results
shown in Table 7 are in good agreement with those
obtained with the comparison method [35]. Statistical ana-

































Figure 5 Application of the proposed method for the
determination of LEV (2 μg/mL) in Spiked human plasma in
0.15 M SDS, 0.3% triethylamine, 8% n-propanol all prepared in
0.02 M orthophosphoric acid at pH 4.0.
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ence between the performance of the two methods re-
garding the accuracy and precision, respectively Table 8.
Figure 4 shows chromatograms of good resolved peaks
of LEV and AMB in their co-formulated tablets with
high sensitivity.2                  4                  6
Retention time, min
Figure 6 Blank plasma in 0.15 M SDS, 0.3% triethylamine, 8%
n-propanol all prepared in 0.02 M orthophosphoric acid at
pH 4.0.Application to biological fluid
After oral administration, LEV is rapidly absorbed
with maximum plasma concentration being reached
approximately one hour after a dose. It undergoes lim-
ited metabolism and is excreted mainly as theunchanged drug in urine (80-85%) and feaces (2%).
About an oral administration of 100 mg dose of the
drug, the mean plasma concentration was 1.35 mg/l
and was observed after 1.8 hour after ingestion [40].
The high sensitivity of the proposed method allowed
the determination of LEV in spiked human plasma.Analysis of spiked human plasma
The proposed method was applied for the determin-
ation of LEV in spiked human plasma without inter-
fering from the plasma peak. Figure 5 shows LEV
peak obtained from spiked human plasma. Table 8
shows the results obtained from spiked plasma.
Under the above described experimental conditions,
a linear relationship was established by plotting the
peak area against the drug concentration in μg/mL
due to overlapping between plasma peak and FUR


















Figure 7 Application of the proposed method for the
determination of LEV in real human plasma after 3 hours in
0.15 M SDS, 0.3% triethylamine, 8% n-propanol all prepared in
0.02 M orthophosphoric acid at pH 4.0.






















Figure 8 Monitoring of the blood level of in patient’s plasma at
different time intervals.
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Where: P is the peak area, C is the concentration of
the drug in μg/mL and r is the correlation coefficient.
The high value of the correlation coefficient (r) indi-
cates the good linearity of the calibration graph
constructed in human plasma.Real human plasma
The plasma samples obtained from the volunteer were
investigated using the previously obtained calibration
graph or regression equation of the spiked human
plasma and the results obtained are shown in Figures 6
and 7. The mean plasma level reached after 3 hours for
LEV and was found to be 5.69 μg/mL. Hence, the pro-
posed method allows the therapeutic monitoring of the
drug level in plasma Figure 8.Conclusion
A simple, accurate and rapid micellar less hazardous and
toxic liquid chromatographic method was examined for
the simultaneous determination of LEV and AMB in
binary mixtures. The proposed method was successful in
elution of LEV ad AMB with retention times at 3.4 min.
and 5.2 min., respectively with a good resolution Rs =
3.81. The proposed method was found to have limits of
detection of 0.26 and 0.07 μg/mL and limits of quantita-
tion of 0.80 and 0.20 μg/mL for LEV and AMB, respec-
tively that is more sensitive than the comparison
method which is linear over the ranges of 7–22 μg/mL
and 50–150 μg/mL for LEV and AMB, respectively. In
addition, it could be applied to the analysis of both drugs
in co-formulated tablets which wasn’t applicable in the
comparison method. The good validation criteria of the
proposed method allow its use in quality control labora-
tories. The proposed procedure, by virtue of its sensitiv-
ity, could be applied to the analysis of LEV in spiked
human plasma with a mean recovery of 100.10 ± 1.14
without prior extraction procedure. In addition to the
drug monitoring of LEV which gave a concentration of
5.69 μg/mL after 3 hours of oral administration of 750
mg of LEV. This seems to be promising in monitoring
LEV level in patients undergoing LEV treatments for a
long period.
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